Sphygmomanometer market seen topping $5.3B by 2030

The global sphygmomanometer market is projected to rise from $3.2 billion in 2025 to $3.53 billion in 2026, with growth tied to hypertension, cardiovascular disease, remote monitoring and the shift away from mercury devices. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through 2030.

Why it matters: - Demand for blood pressure monitors is rising as hypertension and cardiovascular disease cases increase worldwide. - The market is also benefiting from the shift toward home monitoring, telemedicine and connected care. - Faster adoption matters because sphygmomanometers remain a core tool for screening, diagnosis and ongoing management in clinics and homes.

What happened: - The Business Research Company said the global sphygmomanometer market will grow from $3.2 billion in 2025 to $3.53 billion in 2026. - The report projects the market will reach $5.31 billion by 2030. - The forecast implies a 10.3% CAGR in the 2025-2026 period and a 10.7% CAGR through 2030. - The company published the report on Aug. 27, 2026, in London. - Free sample report is available online.

The details: - The report links historical growth to hypertension prevalence, prior use of mercury-based sphygmomanometers, stronger clinical screening, more primary healthcare facilities and wider use of manual and aneroid devices. - The forecast period is expected to be driven by remote patient monitoring, connected healthcare devices, telemedicine, preventive cardiovascular care and replacement of mercury-based products with safer alternatives. - Key trends include digital blood pressure monitors, home-based monitoring systems, data connectivity, portable devices, wearable devices and better accuracy and ease of use. - A sphygmomanometer measures blood pressure, especially arterial pressure, using an inflatable cuff and a gauge. - The device is used in both clinical and home settings. - The report says the rising burden of chronic non-communicable diseases, especially hypertension and cardiovascular conditions, is a major market driver. - The World Health Organization reported in September 2025 that around 1.4 billion adults ages 30 to 79 had hypertension in 2024. - The WHO said about two-thirds of those adults live in low- and middle-income countries. - The WHO also said about 600 million people, or 44%, remain undiagnosed. - The WHO said about 630 million people, or 44%, receive diagnosis and treatment. - The report says growing obesity, sedentary lifestyles, unhealthy diets and aging populations are adding to blood pressure-related demand. - Ambulatory surgery centers are another demand driver because they rely on blood pressure monitoring before, during and after outpatient procedures. - CliftonLarsonAllen LLP said in July 2025 that more than 10,000 ambulatory surgery centers operate in the U.S. - CliftonLarsonAllen also projected the U.S. ASC industry revenue will rise from about $45 billion in 2024 to about $57 billion by 2030. - North America held the largest share of the market in 2025. - Asia-Pacific is expected to be the fastest-growing regional market during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report package includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel forecasting dashboards, market hotspots infographics, key technology analysis and future trend coverage.

Between the lines: - The market shift away from mercury-based devices suggests regulation, safety concerns and product modernization are reshaping purchasing decisions. - Growth in home and connected monitoring points to a broader move toward care outside traditional hospitals. - Asia-Pacific’s faster growth likely reflects expanding healthcare access and rising chronic disease screening, even though North America still leads today.

What's next: - The market is on track for continued double-digit growth through 2030 if demand for monitoring devices keeps rising. - Replacement demand for safer alternatives and adoption of digital devices should remain central themes. - More blood pressure checks in ambulatory settings and at home may keep expanding the addressable market.

The bottom line: - Sphygmomanometers are moving from a routine clinical tool to a growing connected-care category, with chronic disease care and home monitoring driving the next phase of demand.